Toxicology

Toxicology is the scientific study of how substances damage living systems — the mechanisms by which harm occurs, the conditions under which it becomes clinically significant, and the methods used to detect and reverse it.

Within drug references, it appears in two overlapping roles. Research toxicology establishes what a substance does at various exposure levels: the organs it damages, the processes it disrupts, the point at which harm becomes irreversible. Analytical toxicology is the applied discipline that identifies which substances are present in a biological specimen — blood, urine, hair, or tissue — and at what concentrations.

How it is done

Analytical toxicology begins with specimen collection. Different matrices suit different questions: blood reflects recent exposure and current pharmacological state; urine captures a longer excretion window; hair can reveal a pattern of use over months.

Initial analysis typically uses immunoassay panels — high-throughput tests that detect substances by recognising molecular features rather than measuring compounds directly. Because panels target specific compound classes, anything outside their scope will not be flagged.

Positive or ambiguous results proceed to confirmatory analysis, usually chromatography paired with mass spectrometry. This identifies compounds by their precise chemical structure and can distinguish substances that immunoassays cannot separate — including metabolites from parent compounds.

Forensic toxicology, applied in post-mortem investigation, adds the complication of post-mortem redistribution: tissue changes after death can alter a compound's measured concentration substantially, and findings must be interpreted against that background.

When it matters

In an acute emergency — suspected overdose, altered consciousness with unknown substance history — toxicology screening is ordered to help direct treatment. Results rarely arrive in time to guide initial management, which proceeds from the clinical presentation.

When findings do return, they can confirm a suspected substance, narrow a differential, or reveal a co-ingestion that changes the treatment approach. A negative screen does not clear the picture; it means the panel found nothing it was designed to find.

In aggregate, post-mortem toxicology feeds public health surveillance: tracking which substances appear in drug-related deaths and how supply patterns shift over time. Much of what appears as toxicity risk data on substance pages derives from this population-level record.

What it cannot tell you

A toxicology screen reports what was detected above its assay's threshold. It does not establish what was taken, at what amount, or whether a detected substance caused the clinical presentation being investigated.

Standard panels are designed around well-characterised compounds. Novel psychoactive substances are routinely absent from most panels, and a screen returning no findings cannot rule out their presence — only the presence of compounds the panel was built to find.

Cross-reactivity is a documented limitation of immunoassay screens: structurally similar molecules can produce a positive result for a compound not actually present. Confirmatory mass spectrometry resolves this, but is not always performed.

Quantitative results require clinical context. A measured blood concentration does not, by itself, establish toxicity — tolerance, route of exposure, co-ingested substances, and individual differences in metabolism all influence what a given level means. The gap between identified and responsible for harm is where most interpretive errors occur.